| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.4 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |